Genalice, Knome strike NGS rare disease deal; Mayo Clinic creates HealthKit-integrated app;

> Genalice and Knome agreed to provide NGS data processing and analysis tools to a Swiss rare disease foundation. Item

> The Mayo Clinic introduced an iPhone app that integrates with Apple's ($AAPL) HealthKit. Piece

> AstraZeneca ($AZN) signed up to use Decision Lens to prioritize its portfolio. News

> Parexel ($PRXL) bought ClinIntel to expand its randomization and trial supply management offering. More

> FDA reopened the comment period on its social media guidance for 30 days. Notice

> GeneHub canceled its Kickstarter campaign after learning of a trademark violation. News

> LabConnect released software to visualize clinical trial data. Release

> The University of Dundee opened a $42 million building to house its bioinformatics department and other teams. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.